121 related articles for article (PubMed ID: 1980774)
1. [Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors].
Arnold R; Neuhaus C; Trautmann M
Z Gastroenterol; 1990 Sep; 28 Suppl 2():22-8. PubMed ID: 1980774
[No Abstract] [Full Text] [Related]
2. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
Arnold R; Neuhaus C; Trautmann ME
Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
[No Abstract] [Full Text] [Related]
3. An important new treatment for carcinoid tumors and VIPomas.
Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
[No Abstract] [Full Text] [Related]
4. Endocrine tumors.
Averbuch SD
Cancer Chemother Biol Response Modif; 1991; 12():491-508. PubMed ID: 1681844
[No Abstract] [Full Text] [Related]
5. Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis.
Burgess JR; Greenaway TM; Parameswaran V; Shepherd JJ
Cancer; 1999 Nov; 86(10):2154-9. PubMed ID: 10570446
[TBL] [Abstract][Full Text] [Related]
6. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract][Full Text] [Related]
7. Gut neuroendocrine tumors.
Hammond PJ; Bloom SR
Curr Ther Endocrinol Metab; 1994; 5():570-5. PubMed ID: 7704795
[No Abstract] [Full Text] [Related]
8. Octreotide--a synthetic somatostatin.
Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
[No Abstract] [Full Text] [Related]
9. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.
Oberg K
Expert Rev Anticancer Ther; 2009 May; 9(5):557-66. PubMed ID: 19445573
[TBL] [Abstract][Full Text] [Related]
10. The gastroenteropancreatic endocrine system and related tumors.
Solcia E; Capella C; Fiocca R; Cornaggia M; Bosi F
Gastroenterol Clin North Am; 1989 Dec; 18(4):671-93. PubMed ID: 2575601
[TBL] [Abstract][Full Text] [Related]
11. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
[No Abstract] [Full Text] [Related]
12. Vipoma, glucagonoma and the role of Sandostatin.
Bloom SR
NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
[No Abstract] [Full Text] [Related]
13. Octreotide: a somatostatin analog.
Salman K; Rose LI
Am Fam Physician; 1989 Jun; 39(6):207-11. PubMed ID: 2543196
[No Abstract] [Full Text] [Related]
14. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.
Maton PN
Gastroenterol Clin North Am; 1989 Dec; 18(4):897-922. PubMed ID: 2559036
[TBL] [Abstract][Full Text] [Related]
15. Gastro-entero-pancreatic tumours. Proceedings of Somatostatin Analogues--Peptide Therapy in Action Symposium. January 9th, 1989, London.
Digestion; 1990; 45 Suppl 1():1-63. PubMed ID: 2335265
[No Abstract] [Full Text] [Related]
16. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
Ligorria C; Montaña E; Virgili N
Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
[No Abstract] [Full Text] [Related]
17. Somatostatin analogues in the management of benign insulinomas.
Laron Z
Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
[No Abstract] [Full Text] [Related]
18. The surgical approach to endocrine tumors of the pancreas.
Fraker DL; Alexander HR
Semin Gastrointest Dis; 1995 Apr; 6(2):102-13. PubMed ID: 7788282
[No Abstract] [Full Text] [Related]
19. [Pharmacological treatment of gastroenteropancreatic apudomas with an analog of somatostatin, SMS 201-995 (octreotide)].
Varas Lorenzo MJ
Rev Esp Enferm Dig; 1991 Feb; 79(2):95-8. PubMed ID: 2059523
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
Stöckmann F; Creutzfeldt W
Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
